REFERENCES:
ANC 24/7. (2021, August 5). Lung center of PH: Molnupiravir showing promise as COVID-19 treatment | ANC [Video]. YouTube. https://youtu.be/GmqCpygVTwA
de Vera, A. (2021, August 17). Hospitals call for more volunteers in Molnupiravir clinical trials vs COVID-19. Manila Bulletin. https://mb.com.ph/2021/08/17/hospitals-call-for-more-volunteers-in-molnupiravir-clinical-trials-vs-covid-19/
Fischer, W., Eron, J. J., Holman, W., Cohen, M. S., Fang, L., Szewczyk, L. J., Sheahan, T. P., Baric, R., Mollan, K. R., Wolfe, C. R., Duke, E. R., Azizad, M. M., Borroto-Esoda, K., Wohl, D. A., Loftis, A. J., Alabanza, P., Lipansky, F., & Painter, W. P. (2021). Molnupiravir, an oral antiviral treatment for COVID-19. medRxiv. https://doi.org/10.1101/2021.06.17.21258639
Haseltine, W. A. (2021, March 16). Molnupiravir: A New Hope For Prevention And Treatment Of Covid-19 And Other Dangerous Viruses. Forbes. https://www.forbes.com/sites/williamhaseltine/2021/03/16/molnupiravir-a-new-hope-for-prevention-and-treatment-of-covid-19-and-other-dangerous-viruses/?sh=7e6824741200
Laguipo, A. B. (2021, June 28). An oral pill for COVID-19? Molnupiravir shows promise. News-Medical.net. https://www.news-medical.net/news/20210627/An-oral-pill-for-COVID19-Molnupiravir-shows-promise.aspx
Merck. (2021, July 22). Interim results from phase 2/3 studies of Molnupiravir, an Investigational oral antiviral therapeutic for mild to moderate COVID-19, presented at the European Congress of clinical microbiology & infectious diseases (ECCMID). https://www.merck.com/news/interim-results-from-phase-2-3-studies-of-molnupiravir-an-investigational-oral-antiviral-therapeutic-for-mild-to-moderate-covid-19-presented-at-the-european-congress-of-clinical-microbiology-i/
Precision Vaccinations. (2021, August 18). Molnupiravir (MK-4482, EIDD-2801) antiviral. https://www.precisionvaccinations.com/vaccines/molnupiravir-mk-4482-eidd-2801-antiviral
Reuters. (2021, August 13). Merck initiates rolling submission to Health Canada for oral COVID-19 drug. https://www.reuters.com/business/healthcare-pharmaceuticals/merck-initiates-rolling-submission-health-canada-oral-covid-19-drug-2021-08-13/